Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry-Reference-Cited by-同舟云学术

Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry

Published:2009-11 Issue:16 Volume:45 Page:2835-2842
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Garaventa Alberto,Parodi Stefano,De Bernardi Bruno,Dau Daniela,Manzitti Carla,Conte Massimo,Casale Fiorina,Viscardi Elisabetta,Bianchi Maurizio,D’Angelo Paolo,Zanazzo Giulio Andrea,Luksch Roberto,Favre Claudio,Tamburini Angela,Haupt Riccardo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Peripheral neuroblastic tumors;De Bernardi,2008

2. The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97;Schmidt;Eur J Cancer,2008

3. Chemotherapy for patients with recurrent or refractory neuroblastoma: a POG Phase II study;Alvarado;J Pediatr Hematol Oncol,1997

4. Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l’Enfant and United Kingdom Children Cancer Study Group–New Agents Group Study;Rubie;J Clin Oncol,2006

5. Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study;Bagatell;Clin Cancer Res,2007

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Knowledge and Perspectives of Immunotherapies for Neuroblastoma;Cancers;2024-08-17

2. Narrative review: precision medicine applications in neuroblastoma—current status and future prospects;Translational Pediatrics;2024-01

3. Future of Clinical Trials and Application of Precision Medicine;Pediatric Oncology;2024

4. Reaching the target dose with one single ¹³¹I‐mIBG administration in high‐risk neuroblastoma: The determinant impact of the primary tumour;Pediatric Blood & Cancer;2023-12-11

5. Late Relapse in Neuroblastoma: Case Report and Review of the Literature;Current Pediatric Reviews;2023-10-27